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Summary 
Perivascular lesions within the central nervous system (CNS) of rats with hyperacute experimental 
autoimmune encephalomyelitis (HEAE) contained large numbers of peripheral blood mononuclear 
cells (PBMC) and polymorphonudear leukocytes (PMN), cells enzymatically capable of producing 
reactive nitrogen and oxygen intermediates (RNI and ROI), which, in excess, are mediators 
of tissue damage. PBMC and PMN isolated  from the CNS and periphery of HEAE-affected 
rats secreted significantly (p <  0.01-0.0001)  elevated levels of ROI and RNI compared with 
that of similar cell populations from pertussis- and saline-treated control animals. Coincubation 
of systemically derived PBMC and PMN with antigen-stimulated myelin basic protein-specific 
T  cell lines led to further increases in ROI and RNI output of between 15.3 and 83.1%,  an 
effect that could be largely attributed to heat-labile,  soluble products released by these T  cell 
lines. Our studies suggest a putative neuropathological role for ROI and RNI in HEAE, which 
may be mediated via cytokines emanating from autoreactive T  lymphocytes. 
I 
nflammatory cells, notably T cells and macrophages, are 
found within lesions in the central nervous systems (CNS) 
of animals with experimental autoimmune encephalomyelitis 
(EAE) (1). In hyperacute EAE (HEAE), a disease variant used 
as a laboratory model for rapid onset multiple sclerosis and 
acute necrotising hemorrhagic leukoencephalopathy, significant 
numbers of polymorphonuclear leukocytes (PMN) are also 
present (2). Upon activation, both macrophages (3) and PMN 
(4) are major cellular sources of reactive oxygen intermediates 
(ROI). It is now established  that these cells also secrete an 
additional class of effector molecules collectively termed the 
reactive  nitrogen intermediates (RNI),  which include the 
highly unstable species nitric oxide (NO.), as well as its de- 
rivatives,  nitrite (NO2-)  and nitrate  (NO3-)  (5,  6).  The 
strong oxidant properties of ROI and RNI provide potent 
antimicrobial (3, 7), parasiticidal (8), and tumoricidal (9) de- 
fense mechanisms. They are, however, also injurious to normal 
host tissue components (10), suggesting a possible pathogenic 
role in HEAE. 
We report here an elevated secretion of RNI and ROI by 
both systemic and CNS-derived PBMC and PMN from rats 
during HEAE. In addition, the effects of encephalitogenic 
T cells or their soluble products on KOI and KNI secretion 
by these effector cells were examined, since it has been pro- 
posed recently that neurospecific T lymphocytes, through the 
action of cytokines such as TNF-ol and -/3, and IFN-3' (11, 
12), recruit and activate inflammatory cells during EAE. The 
priming effects of these cytokines for inducible KOI (4) and 
KNI  (13) release are well documented. 
Materials and Methods 
Induction of  HEAE.  Under ether anesthesia, 8-10-wk-old  Lewis 
x  DA(F1) hybrid rats (180-220 g) were injected intradermally 
with 125 #1 of guinea pig spinal cord homogenate (400 mg/ml 
in 0.9% NaC1) into each hind footpad along with 0.1 ml of Bor- 
detella pertussis vaccine (101~  heat-killed organisms/ml) (Common- 
wealth Serum Labs, Melbourne, Australia) administered dorsally. 
Control groups received  pertussis vaccine  or saline alone. Clinical 
HEAE, which manifested 6-8 d postinoculum (p.i.), was graded 
according  to the following  criteria: 0, asymptomatic;  1, loss of distal 
half of tail tonicity; 2, loss of entire tail tonicity; 3, hindlimb pa- 
resis; 4, hindlimb paralysis; 5, tetraplegia; 6, death. 
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ripheral blood of HEAE-affected rats, pertussis-immunized, and 
saline-treated controls were separated by Ficoll-Paque centrifuga- 
tion (density 1.089 g/ml; Pharmacia Fine Chemicals AB, Uppsala, 
Sweden) and dextran sedimentation (T-500; Pharmacia  Fine Chem- 
icals AB) subsequent to hypertonic lysis to remove erythrocytes 
(14). Differential staining (Diff"  Quik stain; Lab Stains, Narabeen, 
Australia) showed that PMN fractions were 96.5  +  1.2% pure, 
while PBMC fractions exhibited the following leukocyte profile: 
38.7  +  2.8%  monocytes, 57.4  _+  2.4%  lymphocytes, and 1.5 
+_ 0.8% PMN. Cell viability, as assessed  by trypan blue exclusion, 
was consistently >95%. CNS-derived PBMC and PMN were ob- 
tained from animals that were thoroughly perfused with saline in 
order to remove  nonadherent blood cells. Spinal  cords were removed 
aseptically  and dissected  in RPMI t640 (Gibco Laboratories,  Grand 
Island, NY) containing 50 mg/ml type I collagenase  (Sigma  Chem- 
ical Co., St. Louis,  MO), gently agitated  (15 min, 4~  and screened 
before separating  by Ficoll-Paque  centrifugation. Cell yields  ranged 
from 2 to 3.5  x  104 PBMC and "~5  x  103 PMN per 100 mg 
tissue wet weight. The negligible  hemoglobin  content of  these tissue 
preparations showed that the perfusion technique employed was 
effective. 
Myelin Basic Protein-reactive T Cell Lines.  Cell lines reactive to 
myelin  basic protein (MBP-C) were generated  essentially  as described 
by Ben-Nun et al. (15). At the time of use these cells had been 
in continuous culture for '-5 mo and had CD4*, CDS-, OX22- 
phenotypes. 
Cell  Activation and  Cocuhure Conditions.  MBP-C (1.5  x 
106/ml) were activated  by coculturing them with irradiated (2,000 
rad) syngeneic tliymocytes (IT) (3.5  x  107/ml) for 3 d with 20 
/zg/ml MBP in 50 ml of DME containing 1% autologous serum, 
5  x  10 -5 M 2-ME, 1 mM sodium pyruvate, 2 mM L-glutamine, 
plus penicillin and streptomycin at 37~  in an atmosphere of 5% 
CO2. Nonactivated cells were isolated from the culture by Ficoll- 
Paque centrifugation (14) and cultured for a further 3 d or more 
in DME with 10% FCS and 15% Con A-activated spleen cell su- 
pernatant as a source of IL-2. After the culture period, activated 
or nonactivated MBP-C were centrifuged (500 g, 5 min, 4~  and 
washed twice with PBS. Subsequently, 1.5  x  106 activated or 
nonactivated MBP-C were added to either 106 PBMC for 8 h or 
10  s PMN for 2 h, respectively, in 5.0 ml fresh DME. After coin- 
cubation, cell suspensions were centrifuged (750 g, 10 min, 4~ 
and the pellet was prepared for chemiluminescence (CL), while 
supernatants were set aside for assay of total RNI. Sterile filtered 
(0.22/~m) supernatants  from MBP-C, HEAE-primed PBMC (8 h), 
or PMN ((2 h) were used to investigate the contribution by soluble 
factors to ROI or RNI production, and contained <20 pg/ml en- 
dotoxin as assessed  by limulus amebocyte  assay  (M. A. Bioproducts, 
Walkersville, MD). 
Unstimulated Chemiluminescence.  106 PBMC or  10  s PMN  in 
900/~1 HBSS containing 5 mM glucose  were added to dark-adapted 
disposable glass tubes in the presence of  either 20/~1 luminol (LUM) 
(10 mM) (Boehringer Mannheim Biochemicals, Indianapolis, IN) 
or 50/~1 lucigenin (LUC) (5 raM) (Sigma Chemical Co.) for detec- 
tion of HzO2/HOC1 and 02-, respectively  (16). Cell-free suspen- 
sions served as background controls. CL was recorded over 30 rain 
at 370C in an unstirred system using a multichannel Lumicon lu- 
minometer (Hamilton Bonaduz AG, Bonaduz, Switzerland).  Cubic 
spline interpolated chemiluminescent traces (ANUGraph; ANU 
Tech, Canberra, Australia) were integrated using an Apple Macin- 
tosh Ilcx minicomputer to obtain the total counts/30  min. 
No2- and NO3- Determination.  A microplate assay  method (es- 
sentially as described by R.ockett et al. [8]), using the Griess re- 
agent (1% sulfanilamide  plus 0.1% N-[1-naphthyl]ethylenediamine 
dihydrochloride [Sigma Chemical Co.] in 2.5%  H3PO4), and a 
Zn/Cd/Cu catalyst to discriminate between NO2-  and N03-, 
was used to determine total secreted RNI. 
Cytokine Assays.  TNF-cr  IFN-3,, and II~6 in cell culture su- 
pernatants were measured  in triplicate  using the following  methods: 
(a) TNF-o~ by double sandwich ELISA (17); (b) IrY--r by WEHI- 
279.1 proliferation  assay  with rRat IFN-3~ (Holland Biotechnology 
bv, CA Leiden, The Netherlands) as the standard (18); and (c) IL-6 
via  a  [3H]thymidine incorporation  assay using  the  B  cell hy- 
bridoma, B9 (19). 
Results and Discussion 
Heightened RNI and ROI Secretion from Systemic and CNS- 
derived PBMC and PMN during HEAE.  Independent bio- 
synthetic pathways for RNI and superoxide (O2-) produc- 
tion have been proposed for murine monocytes/macrophages 
(5,  13) and human PMN (6),  although this does not pre- 
clude their concomitant secretion when elicited by suitable 
physiological stimuli. Indeed, circulating and CNS-derived 
monocytes  from  rats  clinically  ill  with  HEAE  secreted 
significantly more (p < 0.0001) RNI and ROI compared with 
pertussis-immunized and saline-treated controls (Fig.  1, a, 
b, and c). Levels of NO~-  +  NO3-  in 8-h supernatants of 
PBMC taken from rats with neurological symptoms were 
some 10-fold  higher (systemically derived)  and 10-15-fold 
higher (CNS-derived) than those from pertussis or saline- 
treated rats (Fig.  1 a). ROI release, like RNI output, was 
substantially elevated in PBMC from sick animals compared 
with either control group as shown by unstimulated chemi- 
luminescence.  Here,  increases  in  H202/HOC1  output  of 
"~8.0 (systemically derived) and between 9.4 and 10.2 times 
(CNS-derived) that of either control group were found (Fig. 
1 b). Corresponding differences for O2-  production (Fig.  1 
c) were less pronounced, with HEAE-affected rats secreting 
'~4 (systemically derived)  and between 3.5 and 3.8 (CNS- 
derived)  times more than controls. 
PMN isolated from HEAE-affected animals exhibited ele- 
vations in ROI output compared with PMN from control 
rats (H202/HOCI, >30 and >35 times, and 02-  >40 and 
>37  times that of control animals for systemic and CNS- 
derived PMN,  respectively;  p  <  0.0001  in each case) (Fig. 
1, e and f). Cumulative RNI production by PMN (Fig.  1 
d) was also greater in sick rats than controls. 
Together these findings suggest that elevations in ROI and 
RNI output are specifically associated with the disease pro- 
cess, a contention supported by the following evidence. First, 
quantitative similarities in all three parameters for cells taken 
from both control groups rule out the possibility that the 
adjuvant,/t pertussis vaccine, alone caused increased ROI or 
RNI secretion. Second,  to assess more accurately their state 
of activation in vivo, PBMC and PMN were isolated without 
elicitation and their CL measured without stimulation in vitro. 
Concurrent experiments using serum-opsonized zymosan were 
also undertaken, and significant differences between HEAE 
and control groups were found (data not shown). 
In addition, the finding that the levels of RNI and ROI 
production by cells obtained from the peripheral circulation 
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Figure  1.  Individual comparison 
of NO2-  +  NO3-,  LUM-CL, 
and LUC-CL  production  by sys- 
temic and CNS-derived  PBMC (a-c) 
and PMN (d-f) of HEAE (O) (n 
=  10) versus pertussis-immunized 
(e) (n = 6) and saline-treated (D) 
(n = 6) control rats. Cells were har- 
vested day 8 p.i., coinciding with 
peak dinical severity  (score: 4.71 +_ 
1.03). All measurements were per- 
formed in duplicate; statistical  differ- 
ences were measured via student's 
t  test. 
versus the central nervous system of the  same animal were 
quantitatively  similar  (Fig.  1)  suggests  that  those cells en- 
tering  the  CNS probably do  so already activated,  contrary 
to the parenchymal activation proposed by others (20).  The 
recent finding that NO.  selectively contributes to the LUM- 
CL of PMA-stimulated  macrophages (21) may under  some 
circumstances be a limitation to the use of CL as a measure 
of ROI  (e.g.,  after pretreatment  with  PMA  [21]). 
Encephalitogenic T Cells and Their Soluble  Products  Augment 
RNI  and  ROI  Release from HEAE-primed PBMC  and 
PMN.  Autoreactive  CD4 +  T  lymphocytes  are  not  only 
responsible for disease induction in EAE, but are also thought 
to  help  localize  and  orchestrate  the  cellular  events leading 
directly to CNS damage (22). The increased secretion of ROI 
and RNI by HEAE-primed PBMC and PMN prompted us 
to consider whether such secretory functions may be iafluenced 
by MBP-C.  CL  and  RNI  responses  of either  PBMC  (106 
cells)  or PMN  (105 cells)  incubated  for 8  and  2  h,  respec- 
tively, in the presence of activated MBP-C (1.5  x  104 cells) 
plus IT (105 cells) showed that encephalitogenic T  cell lines 
have the ability to enhance these effector functions in vitro 
(Fig.  2).  MBP-C were only effective if first activated with 
antigen (Fig. 2; activated MBP-C vs. nonactivated MBP-C), 
and their contribution  to the levels of ROI in these coincu- 
bations,  like  that  of  IT,  was  negligible  (<6.7  x  104 
counts/30  min/llY  cells  for  LUM-CL,  and  <4.4  x  104 
counts/30  min/106  cells  for  LUC-CL)  (data  not  shown). 
Similarly,  neither  the  MBP-C  nor  IT  secreted  significant 
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Figure  2.  Effect on  NO2-  + 
NO3-  or CL of systemically de- 
rived PBMC or PMN coincubated 
with the following: (ll) nonacti- 
rated MBP-C, (1~) activated  MBP-C, 
(EI) activated MBP-C supernatants, 
([]) heat-inactivated  MBP-C super- 
natants, or (I-q) autologous super- 
natants.  PBMC  or  PMN  from 
normal donors (1) cocuhured with 
activated MBP-C. Mean percent in- 
creases were obtained by subtracting 
the sum of concurrently run sepa- 
rate  incubations,  e.g. PBMC  + 
MBP-C,  from the  corresponding 
coincubation  values (PBMC  + 
MBP-C).  Cells for these  experi- 
ments were taken from eight different HEAE-affected rats or four different normal rats, and measurements were performed in duplicate. Supernatants 
of activated MBP-C were heat inactivated at 80~  for 30 min. NO2-  +  NO3- enhancement was corrected for the original amount of RNI in all 
supernatants before coincubation with PBMC or PMN. 
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(8 h) and PMN (2 h) Isolated from Animals with HEAE 
Supernatant  TNF-cr  IFN-3,*  IL-6* 
U/ml 
Activated MBP-C  7.0  _+  0.24  26.76  +  0.5  5.56  +  0.47 
HIA  s MBP-C  0.32  _+  0.11  <0.4  <0.5 
PBMC  1.32  _+  0.24  3.72  _+  0.83  59.68  _+  6.73 
PMN  0.72  _+ 0.19  <0.4  2.28  _+ 0.54 
Data are means  _+  sem for at  least three supernatants. 
* Measured  by ELISA. 
* Measured  by bioassay. 
s Heat inactivated. 
In PBMC activated by MBP-C, O2- production was in- 
creased 83.1%  above the added values for separate MBP-C 
and  PBMC  incubations.  Comparable  large  increases  for 
H202/HOC1  (57.5%) and NO2-  +  NO3-  (42.3%) were 
measured (Fig. 2 a). A role for sensitized T cells in regulating 
PBMC in EAE has previously been demonstrated (23), with 
LUM-CL of EAE donors being reduced by as much as 32% 
after anti-CD4 antibody treatment. Coincubation of PMN 
with activated MBP-C also enhanced the release of O2- by 
45.1%,  H202/HOC1  by 59.4%,  and NO2-  +  NO3-  by 
15.3% (Fig. 2 b) compared with the added values for MBP-C 
and PBMC alone. 
When activated MBP-C were coincubated with PBMC 
or PMN from normal donors, enhancement of ROI and RNI 
release was much less than that seen in cells from HEAE- 
affected animals (Fig.  2). This may merely reflect a greater 
degree of priming of cells taken from sick animals, and equate, 
for example, with an increased level of receptor expression 
for cytokines, as has been shown previously in SJL and B10.PL 
mice with EAE (24). 
The disparate effects of antigen-activated and nonactivated 
MBP-C on P,  NI and ROI production by phagocytes led us 
to examine whether enhancement by activated MBPoC might 
be due to the release of soluble mediators, since autoantigenic 
encounter is known to cause MBP-reactive T  cell clones to 
produce TNF-cffB, IFN-3,, and 1I.-2 (11). Activated MBP-C 
supernatants were, on average, 75 % as effective as activated 
MBP-C at inducing the release of P,  OI and P,  NI from either 
PBMC (Fig. 2 a) or PMN (Fig. 2 b). This observation may 
be accounted for by the presence of cytokines in MBPoC su- 
pernatants, since this effect was abolished by heating at 80~ 
for 30 min (Fig.  2, a and b). Autologous PBMC and PMN 
supernatants did not induce notable increases  in RNI  and 
ROI secretion (Fig.  2 b). The cytokine profiles of these su- 
pernatants are shown in Table 1. TNF-ot, and especially IFN-% 
levels were highest in the supernatants that exhibited the 
greatest enhancing effect (i.e., those from activated MBP-C). 
Low levels of these cytokines were also detected in PBMC 
supernatants, which had a correspondingly smaller influence 
on PBMC effector functions. In the remaining supernatants, 
TNF-cr and IFN-y were near or below the levels of assay 
sensitivity, and these supernatants did not alter RNI or ROI 
output (Fig.  2, a and b). II~6 is reportedly elevated within 
the CNS during EAE (25) and capable of priming the oxida- 
tive burst in PMN and PBMC (26). This cytokine, however, 
was not effective at increasing the oxidative response of phago- 
cytic cells from animals with HEAE, since its level was >10 
times higher in PBMC supernatants (59.7 U/ml; <20% en- 
hancement) than in supernatants from activated MBP-C (5.6 
U/ml;  15-75%  enhancement) (Table  1). 
In summary, our studies indicate a potential role for P,  NI 
and ROI in the pathogenesis of HEAE. A role for the secre- 
tory products of encephalitogenic T  cells in the induction 
of ROI and RNI release has also been identified. Whether 
this relationship translates too a disease-specific mechanism 
is unclear, since nonencephalitogenic MBP-specific cell lines 
were unavailable for this study. Nevertheless,  the involvement 
of ROI and RNI in HEAE pathology is,  we believe,  cer- 
tainly plausible given that the CNS is not particularly well 
protected against oxidative stress (27). Moreover, being both 
a potent vasodilator (28) and neurotoxic (29), NO. may con- 
tribute to the edema and motor dysfunction characteristic 
of HEAE. 
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